Lazarus 3D
- Industry
- Medical Devices
- Founded Year
- 2014
- Headquarters
- Philomath, Oregon, United States
- Employee Count
- 12
Key People
- Jacques Zaneveld - Founder and CEO
- Smriti Zaneveld - Co-Founder
- N. L. - Chief Operating Officer
- C. W. - VP of Pre-Sure Products
- D. K. - Director of Educational Products (Skill-Sure)
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The founding team comprises individuals with over a decade of experience in their respective fields.
The leadership's extensive experience enhances the company's strategic direction and operational execution.
- Clinical Need
-
Aspect: Very Strong
Summary: The demand for patient-specific surgical rehearsal models is high, addressing a critical need in surgical planning.
By enabling surgeons to practice on realistic models, the technology aims to reduce surgical errors and improve patient outcomes.
- Competition
-
Aspect: First mover
Summary: Lazarus 3D is among the pioneers in providing FDA-cleared patient-specific surgical rehearsal models.
Being an early entrant allows the company to establish strong partnerships and brand recognition in the market.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing realistic, patient-specific 3D-printed models presents moderate technical challenges.
While the technology is innovative, continuous R&D is required to maintain accuracy and realism in the models.
- Patent
-
Aspect: Strong
Summary: The company holds patents for its 3D printing processes and materials.
These patents provide a competitive edge and protect the company's intellectual property.
- Financing
-
Aspect: Well-funded
Summary: Lazarus 3D has secured significant funding from reputable investors.
The financial backing supports product development, market expansion, and operational growth.
- Regulatory
-
Aspect: 510k/PMA
Summary: The company's Pre-Sure models have received FDA clearance.
FDA clearance validates the safety and efficacy of the products, facilitating market adoption.
Opportunity Rollup
- Odds of Success
- 4.1
- Peak Market Share
- 5.95
- Segment CAGR
- 10.7%
- Market Segment
- Medical Devices
- Market Sub Segment
- Surgical Training and Planning
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.30 |
| 2 | 0.89 |
| 3 | 2.08 |
| 4 | 4.17 |
| 5 | 5.95 |
Key Takeaway
Lazarus 3D's innovative, FDA-cleared surgical rehearsal models address a critical need in surgical planning, positioning the company for significant growth in the medical devices market.